Efficacy and safety of the S 05985 [perindopril/amlodipine] combination compared with each individual component [perindopril, amlodipine]: Randomised, double-blind, placebo-controlled study over eight weeks in hypertensive patients.
Phase of Trial: Phase II
Latest Information Update: 20 Apr 2018
At a glance
- Drugs Perindopril/amlodipine (Primary) ; Amlodipine; Perindopril
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors IRIS
- 15 Jun 2015 Results of clinical trial program (4 studies) presented at the 25th European Meeting on Hypertension and Cardiovascular Protection.
- 13 Aug 2011 Additional location added as reported by ISRCTN: Current Controlled Trials record.
- 04 Mar 2008 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History